RKVTF (Rakovina Therapeutics) Beginning Cash Position : $2.16 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Rakovina Therapeutics Beginning Cash Position?

Rakovina Therapeutics's Beginning Cash Position for the quarter that ended in Dec. 2024 was $2.16 Mil.

Rakovina Therapeutics's quarterly Beginning Cash Position declined from Jun. 2024 ($1.33 Mil) to Sep. 2024 ($1.22 Mil) but then increased from Sep. 2024 ($1.22 Mil) to Dec. 2024 ($2.16 Mil).

Rakovina Therapeutics's annual Beginning Cash Position declined from Dec. 2022 ($2.07 Mil) to Dec. 2023 ($0.67 Mil) and declined from Dec. 2023 ($0.67 Mil) to Dec. 2024 ($0.31 Mil).

Rakovina Therapeutics Beginning Cash Position Historical Data

The historical data trend for Rakovina Therapeutics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics Beginning Cash Position Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

2.07

0.67

0.31

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial											0.61	0.32	1.33	1.22	2.16

Rakovina Therapeutics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Rakovina Therapeutics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (OTCPK:RKVTF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

7JO:Germany RKV:Canada

Address

595 Burrard Street, P.O. Box 49314, Suite 2600, Three Bentall Centre, Vancouver, BC, CAN, V6B 0A5

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is engaged in drug discovery research, preclinical and clinical development, and regulatory affairs necessary to advance breakthrough innovations to become potential life-changing treatments in the oncology field. Its oncology pipeline has the potential to deliver biomarker-driven treatments for patients across multiple tumor types. Some of its products in the pipeline include kt-2000 AI, kt-3000 series. Rakovina gained exclusive use of the Deep Docking AI Platform, enabling it to significantly speed up identifying potential drugs for DNA damage response.